Edesa Biotech (EDSA) news
Recent news
EdeSa Biotech - Anticipates topline vitiligo study data in Q4 2027
Edesa Biotech has announced that it expects to release topline data from its vitiligo study during the fourth quarter of 2027. This update follows the company’s recent progress in its clinical development pipeline, which includes ongoing trials for its lead therapeutic candidate. The anticipated…
AInvest Wire · 2h agoEdeSa Biotech announces FDA IND clearance for phase 2 vitiligo study
AInvest Wire · 2h agoAirbus SE - Reaching an estimated value of more than US$420 billion by 2045
Airbus SE (EADSY) is positioned for long-term growth, with analysts forecasting significant expansion in the aerospace and defense sectors. While the company's current market capitalization stands at $142.78 billion, industry observers suggest that structural trends in global air travel and defense…
AInvest Wire · 1d agoJapan electronics sellers Yamada, Edion plan merger to create industry giant - NA
Japan’s consumer electronics retailers Yamada Holdings (9831.T) and Edion Corp (2730.T) are reportedly planning a merger , according to Nikkei Asia. Yamada, the country’s largest electronics retailer, and Edion, currently ranked fifth, aim to combine operations to enhance product development and…
AInvest Wire · Jun 4, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.